Results 181 to 190 of about 56,842 (219)
Some of the next articles are maybe not open access.
PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
The Lancet, 1989Two soldiers continued weekly prophylaxis with 300 mg chloroquine base on their return to Australia from Papua New Guinea but were not protected against Plasmodium vivax malaria. Both had symptoms and parasitaemia although plasma concentrations of chloroquine were considerably higher than those regarded as adequate for suppression of vivax malaria ...
K H, Rieckmann, D R, Davis, D C, Hutton
openaire +4 more sources
Trends in Parasitology, 2008
Four Plasmodium species cause malaria in humans: Plasmodium vivax is the most widespread and results in pronounced morbidity. India (population >1 billion) is a major contributor to the burden of vivax malaria. With a resurgence in interest concerning the neglected burden of vivax malaria and the completion of the P.
Hema, Joshi +4 more
openaire +2 more sources
Four Plasmodium species cause malaria in humans: Plasmodium vivax is the most widespread and results in pronounced morbidity. India (population >1 billion) is a major contributor to the burden of vivax malaria. With a resurgence in interest concerning the neglected burden of vivax malaria and the completion of the P.
Hema, Joshi +4 more
openaire +2 more sources
Cultivation of Plasmodium vivax
Trends in Parasitology, 2008Establishment of a continuous line of Plasmodium vivax parasite is crucial to understand the parasite's biology; however, this has not yet been achieved. Beginning in the 19th century, there were several efforts to cultivate this malaria parasite but without much success until the late 1980s.
Rachanee, Udomsangpetch +3 more
openaire +2 more sources
Plasmodium vivax malaria vaccine development
Molecular Immunology, 2001Plasmodium vivax represents the most widespread malaria parasite worldwide. Although it does not result in as high a mortality rate as P. falciparum, it inflicts debilitating morbidity and consequent economic impact in endemic communities. In addition, the relapsing behavior of this malaria parasite and the recent resistance to anti-malarials ...
M, Arévalo-Herrera, S, Herrera
openaire +2 more sources
Trends in Parasitology, 2002
In Bangkok, Thailand, 3-8 February 2002, the Multilateral Initiative on Malaria convened the first malaria conference, Vivax Malaria Research: 2002 and Beyond, devoted entirely to Plasmodium vivax research.
openaire +2 more sources
In Bangkok, Thailand, 3-8 February 2002, the Multilateral Initiative on Malaria convened the first malaria conference, Vivax Malaria Research: 2002 and Beyond, devoted entirely to Plasmodium vivax research.
openaire +2 more sources
Primaquine Resistance in Plasmodium vivax
The American Journal of Tropical Medicine and Hygiene, 1996Reports have appeared calling attention to what has been termed primaquine resistance in Plasmodium vivax in several geographic areas. The possibility exists that primaquine tolerant strains (often referred to as the tropical zone type from the South Pacific and Southeast Asian regions characterized by early and frequent relapses) may have become ...
W E, Collins, G M, Jeffery
openaire +2 more sources
Congenital Plasmodium vivax malaria
Medical Journal of Australia, 1984A case of congenitally acquired Plasmodium vivax malaria in an infant of a Vietnamese refugee is reported. The pathogenesis and treatment of congenital malaria are also discussed briefly. As many Southeast-Asian refugees are now emigrating to Australia, physicians should be aware of this rare form of malaria.
openaire +2 more sources
2016
Of the five species of malaria parasites infecting humans, Plasmodium vivax has the widest global distribution, with more than 80 million people infected each year (Price et al. Am J Trop Med Hyg 77:79–87, 2007) and 2.5 billion people at risk (Gething et al. PLoS Negl Trop Dis 6:e1814, 2012).
Leanne J. Robinson +3 more
openaire +1 more source
Of the five species of malaria parasites infecting humans, Plasmodium vivax has the widest global distribution, with more than 80 million people infected each year (Price et al. Am J Trop Med Hyg 77:79–87, 2007) and 2.5 billion people at risk (Gething et al. PLoS Negl Trop Dis 6:e1814, 2012).
Leanne J. Robinson +3 more
openaire +1 more source
[Plasmodium vivax: therapy update].
Presse medicale (Paris, France : 1983), 2001IMPACT OF PLASMODIUM VIVAX WORLDWIDE: Plasmodium vivax is the most widespread malanal agent in the world. Unlike Plasmodium falciparum, P. vivax can cause early or late recurrence and is not fatal (benign tertian malaria). EMERGENCE OF RESISTANT STRAINS: P.
X, Nicolas +4 more
openaire +1 more source